Destiny Pharma's live biotherapeutic success treating C.Difficile
A live biotherapeutics product used alongside antibiotics can help combat C. difficile infection (CDI).
Stay updated with breaking news from Bioavailability Challenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A live biotherapeutics product used alongside antibiotics can help combat C. difficile infection (CDI).
The CPhI Worldwide exhibitor will show Syloid XDP, a silica carrier designed to convert liquid, waxy, or oily active ingredients into free-flowing powders.
Lonza expands solid-form services at Oregon facility The company has increased capabilities at its Bend, Oregon location, including its SimpliFiH Solutions first-in-human services for small-molecule drugs. Switzerland-based Lonza has increased its solid-form selection services offered at its Bend, Oregon site. The expansion is designed to help complement its SimpliFiH Solutions services, which include phase-appropriate drug substance, product development and manufacture. Michael Grass, head of solid form services for Lonza pharma and Biotech Small Molecules, spoke ...